-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下: 在審閱獲利報告後,我們根據44倍的預期本益比,將12個月目標股價調高44美元至245美元。該預期市盈率為44倍,基於我們2027年每股收益預期5.56美元(上調0.05美元)。這項估值較歷史平均有較大溢價,主要得益於人工智慧措施帶來的卓越息稅前利潤和利潤率成長。此外,鑑於年初的強勁開局,我們將2026年每股收益預期上調0.22美元至4.64美元。 XPO第一季的業績令人鼓舞,公司營收和獲利均超出預期,同時實現了低於0.2%的歷史最低索賠率。公司在多個領域均表現出色:提升服務品質、獲得盈利市場份額、實現高於市場平均水平的價格增長,並透過專有人工智慧技術顯著提高成本效益。我們預計這一強勁業績將持續,2026年和2027年利潤率和利潤均有望實現健康成長。然而,我們認為XPO的估值已基本反映這些改善,其目前的交易價格比五年平均預期本益比24倍高出98%。我們維持「持有」評等。
Related Articles
Shanghai International Airport's Q1 Profit Rises 11%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in the first quarter rose 11% to 577.8 million yuan from the year-ago attributable profit of almost 519.0 million yuan, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 10% year on year to 0.23 yuan from 0.21 yuan.Operating revenue inched 0.8% higher to 3.20 billion yuan from 3.17 billion yuan in the preceding year.
Shanghai International Airport's 2025 Profit Rises 10%, Revenue Climbs 8%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in 2025 rose 9.5% to 2.12 billion yuan from 1.93 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 9% year on year to 0.85 yuan from 0.78 yuan.Operating revenue gained 7.9% to 13.35 billion yuan from 12.37 billion yuan in the previous year.
ResMed CFO to Retire
ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.